809 related articles for article (PubMed ID: 19553633)
1. Herpes zoster vaccination: benefits and barriers.
Komara FA
J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S22-4. PubMed ID: 19553633
[TBL] [Abstract][Full Text] [Related]
2. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
Betts RF
J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
[TBL] [Abstract][Full Text] [Related]
3. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
4. Overcoming barriers to adult immunization.
High KP
J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S25-8. PubMed ID: 19553634
[TBL] [Abstract][Full Text] [Related]
5. Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination.
Gelb LD
J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S18-21. PubMed ID: 19553631
[TBL] [Abstract][Full Text] [Related]
6. Herpes zoster vaccine: clinical trial evidence and implications for medical practice.
Burke MS
J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S14-8. PubMed ID: 17488883
[TBL] [Abstract][Full Text] [Related]
7. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
Holcomb K; Weinberg JM
J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM; Brisson M; Levin MJ
Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
[TBL] [Abstract][Full Text] [Related]
9. Preventing herpes zoster through vaccination.
Gelb LD
Ophthalmology; 2008 Feb; 115(2 Suppl):S35-8. PubMed ID: 18243932
[TBL] [Abstract][Full Text] [Related]
10. Prevention of herpes zoster and its painful and debilitating complications.
Johnson R; McElhaney J; Pedalino B; Levin M
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
[TBL] [Abstract][Full Text] [Related]
11. [Herpes zoster and postherpetic neuralgia - prevention by vaccination?].
Wutzler P
Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S90-4. PubMed ID: 19353479
[TBL] [Abstract][Full Text] [Related]
12. Herpes zoster: epidemiology, natural history, and common complications.
Weinberg JM
J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S130-5. PubMed ID: 18021864
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age.
Tyring SK; Diaz-Mitoma F; Padget LG; Nunez M; Poland G; Cassidy WM; Bundick ND; Li J; Chan IS; Stek JE; Annunziato PW;
Vaccine; 2007 Feb; 25(10):1877-83. PubMed ID: 17227688
[TBL] [Abstract][Full Text] [Related]
14. Zoster vaccine live.
Kockler DR; McCarthy MW
Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
[TBL] [Abstract][Full Text] [Related]
15. [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications].
Marino MG; Bagnato B; Torella I; Franco E
Ig Sanita Pubbl; 2009; 65(3):299-311. PubMed ID: 19629155
[TBL] [Abstract][Full Text] [Related]
16. Vaccination to prevent herpes zoster in older adults.
Gnann JW
J Pain; 2008 Jan; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
[TBL] [Abstract][Full Text] [Related]
17. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
Lu PJ; Euler GL; Jumaan AO; Harpaz R
Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
[TBL] [Abstract][Full Text] [Related]
18. Herpes zoster virus vaccine.
Woolery WA
Geriatrics; 2008 Oct; 63(10):6-9. PubMed ID: 18828650
[TBL] [Abstract][Full Text] [Related]
19. [Zoster vaccine].
Wutzler P
Klin Monbl Augenheilkd; 2010 May; 227(5):384-7. PubMed ID: 20490991
[TBL] [Abstract][Full Text] [Related]
20. Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.
Levin MJ; Schmader K
Herpes; 2007 Sep; 14 Suppl 2():45-7. PubMed ID: 17939896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
